Logo Alfasigma
Alfasigma worldwide
  • Belgium
  • China
  • Czech Republic
  • France
  • India
  • Italy
  • Mexico
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Russia
  • Slovak Republic
  • Spain
  • Switzerland
  • Tunisia
  • Usa
  • Belgium
  • China
  • Czech Republic
  • France
  • India
  • Italy
  • Mexico
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Russia
  • Slovak Republic
  • Spain
  • Switzerland
  • Tunisia
  • Usa
  • Our Company
    • Alfasigma at glance
    • Our purpose
    • Cultural Values
    • Leadership model
    • Our Legacy
    • Ethics&transparency
      • HCP/HCO relationship
      • Patient associations funding
      • Code of ethics
      • Pharmacovigilance
  • Therapeutic Areas
    • All therapeutic areas
    • Gastroenterology
    • Vascular
  • Research & Innovation
  • CSR
  • Financials
  • Contract Manufacturing
  • Our People
  • News & Media
    • Newsroom
    • Media Center
  • Contacts
  • Our Company
    • Alfasigma at glance
    • Our purpose
    • Cultural Values
    • Leadership model
    • Our Legacy
    • Ethics&transparency
      • HCP/HCO relationship
      • Patient associations funding
      • Code of ethics
      • Pharmacovigilance
  • Therapeutic Areas
    • All therapeutic areas
    • Gastroenterology
    • Vascular
  • Research & Innovation
  • CSR
  • Financials
  • Contract Manufacturing
  • Our People
  • News & Media
    • Newsroom
    • Media Center
  • Contacts

Home Newsroom / International

Alfasigma expands its footprints in the U.S. through the acquisition of Pamlab

January 13, 2017

Alfasigma announces the acquisition of Pamlab, a U.S. based company with a leading position in the manufacturing and distribution of medical foods, from Nestlé Health Science....

Read more

© 2020 Alfasigma S.p.A. | VAT 03432221202 | Privacy Policy | Data Subjects Rights | Cookie Policy | Legal Notice